ÂÜÀòÂÒÂ×

Mike Lewis has a strong background in scientific research and leadership roles. Mike started their career as a Post Doctoral Fellow at Yale University in 2005 and worked there until 2008. Mike then joined the Broad Institute as a Group Leader from 2008 to 2015. Following that, they joined Sage Therapeutics, where they have held various positions including Senior Scientist in Pharmacology from 2015 to 2018 and Principal Scientist from 2018 to the present. Mike is currently serving as a Senior Principal Scientist at Sage Therapeutics.

Mike Lewis holds a post-doctoral degree in Behavioral Neuroscience from Yale University, where they studied from 2005 to 2008. Prior to that, they completed their Ph.D. in Behavioral Neuroscience at Temple University, attending from 2000 to 2005. Mike began their academic journey at Miami University, where they received a Bachelor of Arts (B.A.) in Psychology/Neuroscience, studying from 1996 to 2000.